Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Clinical Rheumatology
Published in: Clinical Rheumatology 3/2007

01-03-2007 | Case Report

Psoriatic arthritis and Klinefelter syndrome: case report

Authors: N. Melillo, A. Corrado, L. Quarta, F. D’Onofrio, F. P. Cantatore

Published in: Clinical Rheumatology | Issue 3/2007

Login to get access

Abstract

Psoriatic arthritis (PsA) is a well-known disease characterized by psoriasis and inflammatory joint disease, with distinct clinical and radiological features to differentiate it from other arthropathies. Whereas many cases of coexistence of arthritis and other autoimmune disorders with chromosomal abnormalities have been reported, the occurrence of PsA and Klinefelter syndrome has not been reported previously. A case of Klinefelter syndrome and PsA was reported. This case report emphasizes the role played by sex hormones and chromosomal abnormalities in the pathogenesis of autoimmune disorder, and to our knowledge, this is an uncommon case of a patient with Klinefelter syndrome who developed PsA.
Literature
1.
Helliwell P, Marchesoni A, Peters M, Barker M, Wright V (1991) A re-evaluation of the osteoarticular manifestation of psoriasis. Br J Rheumatol 30:339–345PubMedCrossRef
2.
Bosmansky K, Kopecky S (1979) Progressive polyarthritis and Klinefelter’s syndrome. Fysiatr Revmatol Vestn 57(3):160–163PubMed
3.
Linchiardopol C, Mota M, Panus C (2004) Metabolic changes in Klinefelter syndrome. Rom J Internal Med 42(2):415–422
4.
Adarichev VA, Nesterovitch AB, Bardos T, Biesczat D, Chandrasekaran R, Vermes C, Mikecz K, Finnegan A, Grant TT (2003) Sex effect on clinical and immunologic quantitative trait loci in a murine model of rheumatoid arthritis. Arthritis Rheum 48(6):1708–1720CrossRefPubMed
5.
Holmdhal R, Jansson L, Andersso M, Jonsson R (1992) Genetic, hormonal and behavioural influence on spontaneously developing arthritis in normal mice. Clin Exp Immunol 88(3):472–476
6.
Masi AT, Chatterton RT, Aldag JC (1999) Perturbation of hypothalamic–pituitary–gonadal axis and adrenal androgen function in rheumatoid arthritis: an odyssey of hormonal relationship to the disease. Ann N Y Acad Sci 876:52–53CrossRef
7.
Dessein PH, Joffe BI, Stanwix AE, Moomal Z (2001) Hyposecretion of adrenal androgen dehydroepiandrosterone sulfate and its relation to clinical variables in inflammatory arthritis. Arthritis Res 3(3):183–188CrossRefPubMed
8.
Cutolo M, Seiolo B, Pizzorni C, Sulli A (2001) The role of androgen in rheumatic disease. Isr Med Assoc J 3:743–748PubMed
9.
Kanda N, Tsuchida T, Tamaki K (1996) Testosterone inhibits immunoglobulin production by human peripheral blood mononuclear cells. Clin Exp Immunol 106(2):410CrossRefPubMed
10.
Cutolo M, Strab RH (2000) Recent aspects of gonadal hormone and neurotrasmitter interaction with synovial and immune cells: implication in rheumatoid arthritis. Ann Rheum Dis 59:657–661CrossRefPubMed
11.
Bizzarro A, Valentini G, Di Martino G, Da ponte A, De Bellis A, Iacono G (1987) Influence of testosterone therapy on clinical and immunological features of autoimmune disease associated with Klinefelter’s syndrome. J Clin Endocrinol Metab 64(1):32–36PubMed
12.
Harbuz MS, Korendowych E, Jessop DS, Crow AL, Lipdfan SL, Kirwan JR (2003) Hypothalamo–pituitary–adrenal axis dysregulation in patient with rheumatoid arthritis after the dexamethasone/corticotrophin releasing factor test. J Endocrinol 178(1):55–60CrossRefPubMed
Metadata
Title
Psoriatic arthritis and Klinefelter syndrome: case report
Authors
N. Melillo
A. Corrado
L. Quarta
F. D’Onofrio
F. P. Cantatore
Publication date
01-03-2007
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 3/2007
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-005-0153-6

Other articles of this Issue 3/2007

Clinical Rheumatology 3/2007 Go to the issue

Original Article

Rheumatologic aspects of lysosomal storage diseases

Original Article

Paraoxonase and arylesterase levels in rheumatoid arthritis

Original Article

Ethnicity may be a reason for lipid changes and high Lp(a) levels in rheumatoid arthritis

Case Report

Juvenile rheumatoid arthritis manifesting in only limping due to flexion contraction of the knee

Original Article

Age as a predicting factor in the therapy outcome of multidisciplinary treatment of patients with chronic low back pain—a prospective longitudinal clinical study in 405 patients

Review

A possible link between Crohn’s disease and ankylosing spondylitis via Klebsiella infections
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits